A mouse model of tafazzin deficiency, which effectively mimics the major molecular and physiological features observed in BTHS patients, may provide a better understanding of how tafazzin deficiency affects cardiac lipid compositions and pathogenesis of BTHS. The gene discussed is TAFAZZIN; the disease is Barth syndrome.